Who owns cabaletta Bio Inc?

The company was founded by Michael C. Milone, Steven Nichtberger, and Aimee Payne in April 2017 and is headquartered in Philadelphia, PA. CABA | Complete Cabaletta Bio Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

How far is cabaletta bio stock from the 52-week high?

The high in the last 52 weeks of Cabaletta Bio stock was 22.41. According to the current price, Cabaletta Bio is 99.78% away from the 52-week high. What are analysts forecasts for Cabaletta Bio stock? The 31 analysts offering price forecasts for Cabaletta Bio have a median target of 19.77, with a high estimate of 50.00 and a low estimate of 3.00.

What is the target price for cabaletta bio?

The 31 analysts offering price forecasts for Cabaletta Bio have a median target of 19.77, with a high estimate of 50.00 and a low estimate of 3.00. The median estimate represents a 113.08 difference from the last price of 22.36. U.S. stocks traded mostly higher, with the Nasdaq Composite gaining more than 100 points on Thursday.